Deep, focused future-generation sequencing has unveiled that subclonal mutations (i.e., those current in just a portion of tumor cells) can be detected for all driver genes and so are associated with speedy disorder development and lousy outcome.11–13 This is particularly suitable for TP53As a consequence of larger nuclease security and longer ha